Importantly, we demonstrated that Sox7 inhibited Wnt/β-catenin signaling in endometrial or endometrioid ovarian cancer cells (OEA) harboring not only wild-type but also mutant β-catenin. This evidence concerns the gene SOX7 and ovarian endometrioid adenocarcinoma.